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Purpose: The purpose of this study was to assess indications for stereotactic vacuum-assisted breast biopsy (SVAB)
evaluated by breast 3 T-magnetic resonance (3 T-MR) imaging in patients showing suspicious microcalcifications on
mammography and negative ultrasound (US) findings.
Methods and materials: Fifty-five patients with 55 breast lesions showing suspicious microcalcifications on
mammography and negative US findings underwent preoperative 3 T-MR examination including dynamic MR
imaging. All patients underwent SVAB within 1 month of MR imaging. The pathological diagnosis of each breast
lesion was made by examining tissues obtained by SVAB or radical/partial mastectomy.
3 T-MR imaging findings were evaluated by using the American College of Radiology Breast Imaging Reporting and
Data System Atlas (BI-RADS-MRI) and then were correlated with the histopathological findings. When BI-RADS 4 and
5 MR imaging lesions were assumed to be malignant, the usefulness of 3 T-MR imaging was evaluated for diagnosis
of impalpable breast lesions by SVAB among lesions with microcalcification detected by mammography and negative
US findings.
Results: There were 21 malignant lesions, including 5 invasive ductal carcinomas, 16 lesions of ductal carcinoma in situ
(DCIS). The sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of 3 T-MR imaging
for deciding the indications for SVAB was 90.5%, 97.1%, 95.0%, 94.3%, and 94.5%, respectively. The one-false negative
case was a DCIS with small enhancing lesions (0.5 mm). The one false-positive case was ductal adenoma with a linear
ductal pattern of enhancement.
Conclusions: 3 T-MR imaging may be useful for deciding the indications for SVAB in patients who have breast lesions
with microcalcification that are impalpable and are detected by mammography and negative US findings.
However, our findings should be considered preliminary and further prospective investigation is required.
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breast biopsyIntroduction
Percutaneous imaging-guided breast biopsy is widely used
to evaluate predominantly impalpable breast lesions.
There has been steady development of percutaneous
biopsy techniques and stereotactic vacuum-assisted
breast biopsy (SVAB) has been established as a reliable
method for the diagnosis of impalpable lesions with
microcalcification detected by mammography (Kikuchi* Correspondence: yosizako@med.shimane-u.ac.jp
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in any medium, provided the original work is pet al. 2007; Nakamura et al. 2010). The high accuracy
of SVAB diagnosis has led to a steady decline in the
performance of diagnostic open surgical biopsy (O'Flynn
et al. 2010). SVAB is much less invasive than conventional
open biopsy. However, it still involves physical and mental
burdens for the patient, so it is important to avoid un-
necessary procedures.
Breast magnetic resonance (MR) imaging has increas-
ingly been performed over the past 10 years because of
its well-documented high sensitivity for detecting breast
cancer, especially occult tumors missed by conventional
imaging modalities (Kuhl et al. 2007; Pediconi et al. 2007;is an Open Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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tumors typically exhibit increased vascularity, an early
remarkable enhancement and some specific pattern of
contrast enhancement, an essential part of many breast
MR studies is T1-weighted dynamic contrast-enhanced
imaging.
In recent years, MR scanners with stronger magnetic
fields (such as 3 T scanners) and thus a higher signal-to-
noise ratio have become more widely available and have
opened up new horizons for contrast-enhanced breast
MR imaging (Elsamaloty et al. 2009; Kuhl et al. 2006;
Rahbar et al. 2013; Lourenco et al. 2014).
The purpose of this study was to assess indications
for stereotactic vacuum-assisted breast biopsy (SVAB)
evaluated by breast 3 T-MR imaging in patients showing




Our Institutional Review Board approved this retrospect-
ive study and the need to obtain informed consent was
waived. The inclusion criteria were women undergoing
screening of lesions with microcalcification classified as
Breast Imaging Reporting and Data System (BI-RADS)
(American College of Radiology 2003) categories 3, 4, or
5 without a detectable mass on mammography or US. A
retrospective review was performed of all patients who
underwent 3 T-MR imaging for evaluation of calcified
breast lesions from January 2010 to June 2012 and who
had pathologic confirmation of the diagnosis. Pathological
diagnosis of the breast lesions was performed by examining
tissues obtained by SVAB or radical/partial mastectomy.
The general exclusion criteria for MR imaging (claustro-
phobia, pregnancy, pacemaker, etc.) were applied.
A total of 57 patients with microcalcifications consid-
ered to be BI-RADS category 3 and over, detected on
mammography, were initially recruited at our institution.
However two patients were excluded because of positive
US findings. Moreover, one person with category 3 was
performed a SVAB on the hope of the patient. As a
consequence, this study included 55 women with calcified
breast lesions who underwent 3 T-MR breast imaging. All
patients subsequently underwent SVAB within 1 month of
MR imaging. The mean age was 53 years (range: 31–82
years). MR imaging of both breasts was performed in all
patients, so imaging data for 110 breasts were obtained.
Imaging protocols
Mammography and interpretation
Bilateral digital mammography was performed using a
LoRad M-IV (Lorad/Hologic, Danbury, Conn., USA).
Images of both breasts were obtained in the routine
craniocaudal and mediolateral oblique views along withspot-magnification views of the areas with microcalcifi-
cation. Digital mammograms were independently read
by two experienced radiologists (N. Y., K. Y.) using the
BI-RADS assessment categories (American College of
Radiology 2003). If the two readers differed in their
assignment of BI-RADS categories, they reached a con-
sensus by discussion. Microcalcification was classified
according to the BI-RADS description of mammog-
raphy features, including assessment of the morphology
(punctate, amorphous, pleomorphic, or linear) and the
distribution (diffuse, regional, clustered, segmental, or
linear) (American College of Radiology 2003).
Breast US and interpretation
Based on the clinical and mammography findings, bilateral
whole breast US was performed before MR imaging and
SVAB. US was done with a linear array broadband trans-
ducer at a central frequency of 10–12 MHz (EUB-7500;
Hitachi Medical Corporation, Tokyo, Japan), and the find-
ings were interpreted by a single experienced radiologist
(N. Y.). Based on the US findings, lesions that required US-
guided core needle breast biopsy in the judgment of a single
experienced surgeon (M. I.) were excluded from this study.
Breast MR imaging and interpretation
MR imaging was performed using a 3.0 T system (Signa
HDx, GE Healthcare, Milwaukee, WI, USA). A body coil
was employed for transmission, and a double breast coil
(eight-channel breast array coil) was used for receiver. MR
examinations have not considered the menstrual cycle.
Before administration of contrast medium, sagittal and
coronal fat-suppressed T2-weighted images (TR/TE, 5,000/
80; field of view, 20 cm; matrix, 256 × 224; slice thickness,
4 mm; acquisition time, 135 seconds) were obtained of the
breast with microcalcification.
Then dynamic MR imaging was performed using a
volume imaging for breast assessment (VIBRANT) se-
quence with parallel acquisition. VIBRANT sequences
were acquired before and four times after injection of a
bolus of gadodiamide (0.1 mmol/kg; Omni scan, Daiichi
Sankyo Tokyo Japan) at a rate of 2 mL/s (followed by
flushing with 20 mL of saline) using an automatic injector.
Both breasts were examined in the axial plane using the
first-, second-, third-, and fourth-phase dynamic images
acquired at 1.5, 3, 4.5, and 6 minutes after contrast
injection, respectively. The parameters for dynamic MR
imaging were as follows: TR/TE, 5.8/2.1; flip angle, 10°;
field of view, 28 cm; matrix, 320 × 320; receiver band-
width, 260 Hz per pixel; interpolated slice thickness,
1.4 mm; partitions, 128; and acquisition time, 90 seconds.
Image analysis was performed on a GE workstation.
Two radiologists (N. Y. had 11 years and T. Y. had 13 years
of experience in breast MR imaging), who made consensus
decisions about the diagnosis, evaluated the contrast-
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of the mammography findings, and assigned each breast to
a category on a patient-to-patient basis. For diagnosis, the
BI-RADS-MRI classification proposed by the American
College of Radiology (Molleran & Mahoney 2013) was
used. Early enhancement patterns were evaluated on
the first- and second-phase dynamic images, while delayed
enhancement was assessed on the third-phase images.
Early enhancement patterns were based on dynamic
signal intensity-time curves. Two radiologists (N. Y., T. Y.)
obtained dynamic signal intensity-time curves by placing a
region of interest in the area of maximal enhancement
within the microcalcification lesions. Lesions were catego-
rized using the flowcharts and interpretation method of
Tozaki et al. (Tozaki & Fukuda 2006; Tozaki & Fukuma
2009) and Akita et al. (Akita et al. 2009) (Table 1).SVAB protocol and management
First, the patient was positioned prone on a digital
stereotactic table (LoRad DSM; Lorad/Hologic, Danbury,
Conn., USA). Then SVAB was performed by one radiologist
or one surgeon using a vacuum-assisted biopsy device with
a 7 or 8-gauge probe (Mammotome; Ethicon EndoSurgery,
Cincinnati, Ohio, USA). After SVAB, digital radiography of
the biopsy specimen was routinely performed to check
whether the tissue containing microcalcification had been
collected. If malignancy was confirmed by pathological
examination of the SVAB specimen, the surgeon proceededTable 1 Categorization of breast lesions on
contrast-enhanced MRI
BI-RADS Appearance on contrast-enhanced MR imaging
Mass lesion
Category 5 Spiculated margin Irregular lesion: rapid washout
pattern and rim enhancement
Category 4b Irregular lesion Smooth margin: washout pattern
Category 4a Smooth margin: nonwashout and initial rapid rise
Category 3 Smooth margin: neither washout nor initial rapid rise
Non-mass
lesion
Category 5 Segmental distribution and clustered ring enhancement
Category 4b Segmental distribution, Branching ductal pattern,
Clustered ring enhancement, Clumped architecture
Category 4a Linear ductal pattern
Category 3 Not showing the characteristics of category 4 or 5
Focus
(<5 mm)
Category 4a Rapid washout pattern
Category 3 Without rapid washout pattern
Category 1, 2 No abnormal enhancement, bilaterally symmetrical
enhancementto definitive surgical intervention. If SVAB revealed a high-
risk lesion, such as atypical ductal hyperplasia (ADH),
the surgeon performed excision biopsy. If a benign lesion
was detected by pathological examination, the patient was
scheduled for repeat mammography of the ipsilateral breast
after 6 months and annual screening mammography was
recommended thereafter. In this study, a diagnosis of
“benign” was defined as no malignancy on SVAB and no
change of the microcalcification on follow-up mammog-
raphy for one year.
Histopathological examination
The histopathological diagnosis was determined by a single
experienced pathologist (R. M.). The reference standard
was serial 5-mm slices of the surgical specimens. The
maximum diameter of the malignant lesions was estimated
by one pathologist by tumor mapping based on the results
of microscopic examination.
Data analysis
In the BI-RADS classification, categories 4 and 5 are
considered to be malignant. In the MR classification,
categories 4 and 5 were also considered to be malignant.
We calculated the sensitivity, specificity, positive predict-
ive value (PPV), negative predictive value (NPV), and
accuracy of mammography alone and mammography
plus MR imaging for diagnosing microcalcification as
benign or malignant using 2 × 2 contingency tables. Fisher’s
exact test and the Mann–Whitney U-test were employed
to examine statistical significance. All statistical analyses
were performed using SPSS software (version 22, SPSS)
and P < 0.05 was considered statistically significant.
Results
SVAB and histopathology
SVAB was performed successfully in all 55 patients with-
out any complications. Digital radiography confirmed that
all specimens contained microcalcification. Examination
of the biopsy specimens revealed that 21 patients (38.2%)
had carcinoma and 34 patients (61.8%) had benign disease
(Table 2). In the patients with malignant lesions, surgical
excision was performed. The final histopathological diag-
nosis was invasive ductal carcinoma in five patients, DCIS
in 16 patients. The DCIS lesions were classified as low,
intermediate, and high grade in 3, 7, and 6 cases, respect-
ively. The maximum diameter of the 16 DCIS lesions
ranged from 0.5 to 110 mm (mean: 38.2 mm), while the
maximum diameter of the 5 invasive ductal carcinomas
ranged from 9 to 30 mm (mean: 17.1 mm). For all malig-
nant lesions, the mean maximum diameter was 21.5 mm.
The 34 patients with benign disease had mastopathy
(n = 7), calcification (17), ductal adenoma (n = 1), fibro-
cystic change and sclerosing adenosis (n = 1), intraductal
papilloma (n = 1), papillomatosis (n = 1), atypical ductal
Table 2 Stereotactic vacuum-assisted breast biopsy





Epitheliosis (duct papillomatosis) 1
Mastopathy 7
Calcification 17
ADH (atypical ductal hyperplasia) 2
No malignancy 4
Malignancy 21
IDC (papillotubular carcinoma) 5
DCIS (high grade) 6
DCIS (intermediate grade) 7
DCIS (low grade) 3
Total 55
Table 3 Morphology and distribution of
microcalcifications on mammography
Calcification BI-RADS category Total Histopathology
3 4 5 Benign Malignancy
Morphology
Punctate 1 - - 1 1 -
Amorphous - 10 7 17 10 7
Pleomorphic - 32 5 37 23 14
Linear - - - - - -
Distribution
Diffuse - 1 - 1 - 1
Regional - 1 - 1 1 -
Clustered - 28 6 34 22 12
Segmental 1 11 6 18 10 8
Linear - 1 - 1 1 -
Total 1 42 12 55 34 21
Benign 1 31 2 34
Malignancy - 11 10 21
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according to histopathologic examination. These patients
with benign lesions were advised to undergo follow-up
imaging according to our institutional protocol, and all 34
complied. The duration of follow-up ranged from 370 to
860 days. There was no evidence of false-negative diagno-
sis because no progression of microcalcification at the site
of SVAB was revealed by follow-up mammography.
Mammography findings
When assessment of the mammography findings was based
on the BI-RADS categories, one of the 55 lesions (1.8%)
was assigned to category 3, while 42 lesions (76.4%) were
category 4 and 12 lesions (21.8%) were category 5 (Table 3).
The PPV for malignancy in categories 3, 4, and 5 was 0%
(0/1), 26.2% (11/42), and 83% (10/12), respectively.
With regard to morphology, the one lesion with punc-
tate microcalcification was benign, while 41.2% of lesions
with amorphous microcalcification (7/17) and 37.8% of
those with pleomorphic microcalcification (14/37) were
malignant. With respect to the distribution of calcification,
100% of the lesions showing diffuse microcalcification
(1/1), 0% of those with regional microcalcifications (0/1),
35.3% of lesions with clustered microcalcification (12/34),
and 44.4% of lesions showing segmental microcalcification
(8/18) were malignant.
Breast MR imaging findings
Fifty-five patients with impalpable 55 breast lesions show-
ing suspicious microcalcifications on mammography and
negative US findings underwent preoperative 3 T-MR
examination, including dynamic MR imaging. There were
no women who could not get scanned due to renalproblems/claustrophobia etc. Moreover, second another
lesion were not identified at MR imaging in this patient
group.
Based on MR imaging findings, 21 lesions were in cat-
egories 1 or 2, 14 lesions were in category 3, one lesion
was in category 4a, 17 lesions were in category 4b, and
two lesions were in category 5 (Table 4, Figures 1 and 2).
Category 1 (no abnormal enhancement) and category 2
(bilateral symmetrical enhancement) accounted for 20
benign lesions and one malignant lesion (high-grade
DCIS with a diameter of 0.5 mm). In category 3, there
were 13 benign lesions and one malignant lesion (low
grade DCIS). The one lesion in category 4a was benign
(ductal adenoma). Category 4b had no benign lesions
and all 17 lesions in this category were malignant. Both
of the two lesions in category 5 were also malignant.
Among lesions classified as category 4 or higher, only
one malignant lesion was a mass lesion, while one benign
lesion and 18 malignant lesions were non mass lesions.
The detection rate of malignancy in category 3, category
4, and category 5 was 7.1% (1/14), 94.4% (17/18), and 100%
(2/2), respectively. Malignant lesions were more frequent
when the MR imaging diagnosis was positive (categories 4
or 5) than when MR imaging was negative (categories 1, 2,
or 3) (Fisher’s exact test, P < 0.001). The number of benign
and malignant lesions in each category was significantly
different (Mann–Whitney U-test, P < 0.001).
If BI-RADS categories 4 and 5 were assumed to be
malignant, for selecting lesions that required SVAB,
3 T-MR imaging for lesions with microcalcification had
a sensitivity of 90.5%, specificity of 97.1%, PPV of 95.0,
NPV of 94.3%, and accuracy of 94.5%.
Table 4 Categorization and case number of breast lesions on contrast-enhanced MRI
BI-RADS category Appearance on contrast-enhanced MR imaging Sub-total Benign Malignancy
Mass lesion
Category 5 Spiculated margin Irregular lesion: rapid washout pattern and rim enhancement - - -
Category 4b Irregular lesion Smooth margin: washout pattern 1 - 1
Category 4a Smooth margin: nonwashout and initial rapid rise - - -
Category 3 Smooth margin: neither washout nor initial rapid rise - - -
Non-mass lesion
Category 5 Segmental distribution and clustered ring enhancement 2 - 2
Category 4b Segmental distribution, Branching ductal pattern,
Clustered ring enhancement, Clumped architecture
16 - 16
Category 4a Linear ductal pattern 1 1* -
Category 3 Not showing the characteristics of category 4 or 5 6 6 -
Focus (<5 mm)
Category 4a Rapid washout pattern - - -
Category 3 Without rapid washout pattern 8 7 1 (DCIS)
Category 1, 2 No abnormal enhancement, bilaterally symmetrical enhancement 21 20 1**
Total 55 34 21
*Ductal adenoma, **DCIS with a diameter of 0.5 mm
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Mammographically detected microcalcification is a fre-
quent feature of breast tumors with early diagnosis, and
is found in approximately 70% of minimal breast cancers
and frequently detected in DCIS (Stomper & Margolin
1994). Stomper et al. (Stomper et al. 1989) reported that
the presence of microcalcification on mammography was
the only sign in 72% of clinically occult DCIS lesions.
Because of the wider adoption of mammography, an in-
creasing number of women with microcalcification on
mammography are undergoing SVAB for more detailed
examination. SVAB has some advantages for assessing
microcalcification because it shows excellent sensitivity
and specificity with a very low false-negative rate (KettritzFigure 1 Ductal carcinoma in situ (DCIS) with calcifications in the right
with spot compression magnification demonstrates non mass-like segmental
(b) Axial contrast-enhanced T1-weighted fat-suppressed MR images of bilater
ring enhancement in the area of microcalcifications (arrow). This finding waset al. 2004; Pfarl et al. 2002). However, approximately 75%
of lesions that are detected, suspected, or indeterminate
on mammography are found to be benign by biopsy
(Kopans 1989), implying that many patients undergo
biopsy unnecessarily because the indications for SVAB
have not yet been fully established.
In the present study, when categories 4 and 5 of BI-
RADS were assumed to be malignant, 3 T-MR imaging
for lesions with microcalcification had a high sensitivity,
specificity, PPV, NPV and accuracy for deciding the
indication for SVAB. The one false negative lesion (high-
grade DCIS) were less than 1.0 mm in diameter on
pathology and was very small clustered pleomorphic
microcalcification and bilaterally symmetrical enhancement.breast of a 50-year-old woman. (a) Right craniocaudal mammogram
amorphous microcalcifications classified as BI-RADS category 4 (circle).
al breasts is showing non mass-like segmental distribution and clustered
classified as BI-RADS category 5.
Figure 2 Secretory form calcifications in the left breast of a 62-year-old woman. (a) Left mediolateral mammogram with spot compression
magnification demonstrates non mass-like clustered amorphous microcalcifications classified as BI-RADS category 4 (circle). (b) Axial contrast-enhanced
T1-weighted fat-suppressed MR images of bilateral breasts is showing non mass-like focus enhancement in the area of microcalcifications (arrow). This
finding was classified as BI-RADS category 3.
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lesions on excisional biopsy. The prognosis of such
cases might be favorable, so frequent follow up would
be one choice. Therefore, 3 T-MR imaging for lesions
with microcalcification might have sufficiently high
sensitivity, specificity, PPV, NPV, and accuracy to decide
the indications for SVAB. 3 T-MR imaging may be useful
to determine candidate lesions for SVAB after mam-
mography detects microcalcification. When the candi-
date lesion shows abnormal enhancement along with
calcification, it should be subjected to SVAB. If the
lesion has no abnormal enhancement on MR imaging,
follow up could be a good choice.
Of course, 3 T-MR imaging depends on the ability of
radiologists to identify and accurately characterize breast
lesions. At a higher field strength, improved detection can
be achieved through better spatial resolution, more homo-
geneous fat suppression, and a higher contrast-to-noise
ratio, while characterization of lesions may be improved
through better spatial and/or temporal resolution. This
should allow better visualization and characterization of
enhancing lesions, which may improve the detection of
breast cancer (Rahbar et al. 2013; Lourenco et al. 2014).
Lourenco et al. (Lourenco et al. 2014) reported that the
detection rate of cancer and the PPV of BI-RADS in
breast screening were improved by 3 T-MR imaging
compared with 1.5 T-MR imaging.
In our study, lesions were categorized using the inter-
pretation flowcharts and interpretation method of Tozaki
et al. (Tozaki & Fukuda 2006; Tozaki & Fukuma 2009)
and Akita et al. (Akita et al. 2009). Tozaki et al. (Tozaki &
Fukuda 2006) reported that the features of microcalcifica-
tion with the highest PPV for carcinoma were a segmental
distribution (100%), clustered ring enhancement (100%),
and clumped internal architecture (88%). Using their
interpretation model, they reported that the PPV for
carcinoma was 94%. The results of our study were similar
to their findings. One false-positive non-mass lesion (ductaladenoma) was found by MR imaging criteria in our study.
This false-positive lesion (ductal adenoma) showed linear
ductal enhancement. Tozaki et al. (Tozaki & Fukuda 2006)
have suggested that linear enhancement might be stratified
into two categories (linear nonspecific and linear ductal
patterns) because the frequency of malignancy in these
categories is different.
Akita et al. (Akita et al. 2009) reported that no malig-
nancy was found in category 1 (no abnormal enhancement
in both breasts) and category 2 (bilateral symmetrical
enhancement), which may have contributed to the high
specificity (100%) in their study. However, there was
one false-negative case belonging to category 2 in our
study. DCIS sometimes shows indistinct enhancement
on MR imaging because of relatively poor or absent
angiogenesis (Ghai et al. 2005). Moreover, the one false-
negative lesion (high-grade DCIS) was less than 1.0 mm in
size and thus were very small. Therefore, it should be
remembered that very small calcified lesions (less than
1.0 mm) may be false negative on MR imaging.
This study had several limitations. First, it was a retro-
spective analysis. As a result, there is a difficulty in repro-
ducibility of the result by various bias occurring, so
prospective confirmation is required. Second, there was
a relatively small study population. Third, the study was
limited by a short follow-up period for benign lesions
diagnosed by SVAB. Thus, a larger study and more out-
come data are needed to confirm our results.
In conclusion, 3 T-MR imaging may be useful for decid-
ing the indications for SVAB in patients who have breast
lesions with microcalcification that are impalpable and are
detected by mammography and negative US findings.
However, our findings and conclusions should be consid-
ered preliminary and further prospective investigation is
required.Competing interests
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